We worked with a pre-clinical drug discovery company with first round funding from friends, family, and angel investors to put in place financial and reporting controls. We cleaned up the financial statements, implemented internal financial controls and a monthly Board report. We implemented a cash forecast to get a true reading on the cash runway.
We worked with an early stage Artificial Intelligence analytics company. We recast (revamped) the statement of operations into categories that made sense for their business, built a P&L to allow the full team to make better decisions. We implemented a tight monthly financial close, in conjunction with a detailed operating budget for actual vs. budget revenue and cost analysis.
We worked with a Series B funded medical device company to develop and implement a detailed monthly operating budget for 2020-2023. The detailed, long-term budget was integral to the planning for the transition from pre-clinical to clinical studies. Worked with all members of the executive management team to ensure long-term buy-in and focus.
Copyright © 2019 Fleming CFO - All Rights Reserved.
Fleming CFO is a division of BOOMCOM, INC.